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DNA damage marker γH2AX is a potential predictive marker for progression of 
epithelial dysplasia of the oral cavity!
Leung&EY1,&McMahon&JD2,&McLellan&D2,&Syyed&N2,&McCarthy CE3,&Nixon&C4,&Orange&C2,&
Brock&C4,&Hunter&K3*&and&Adams&PD4*.&
1.& Wolfson& Wohl& Cancer& Research& Centre,& Institute& of& Cancer& Sciences,& University& of&
Glasgow,&Garscube&Estate,&Switchback&Road,&Glasgow,&G61&1QH,&United&Kingdom&
2.& Queen&Elizabeth&University& Hospital,& 1345&Govan&Road,&Glasgow,&G51& 4TF,& United&
Kingdom&































To& evaluate& the& relationships& between& immunohistochemical& markers& related& to&
cellular&senescence,&cell&proliferation&and&histological&grade&of&epithelial&dysplasia&of& the&






Ki67,& γH2AX,& p53,& p16,& H3K9me3& and& CycD1.& Three& separate& areas& representing& the&
highest& severity& of& OD& on& each& slide& were& digitally& annotated& by& two& independent&
pathologists.&Mean& automated& histoscores& of& the& selected&markers&were& generated& and&





Ki67& (p<0.0001),& γH2AX& (p=0.03)& and& p53& (p=0.04)& were& significantly& increased&
with& higher& histological& grade& of&OD.& γH2AX& (p=0.03),& but& not& histological& grade& of&OD&
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Although& proliferation&marker&Ki67,&DNA&damage/checkpoint&markers& γH2AX&and&
p53& were& increased& in& higher& grade& of& OD,& only& γH2AX& was& predictive& of& disease&
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Introduction!
Although& oral& cancer& accounts& for& only& 3%& of& all& cancer& cases,& its& worldwide&
incidence&has&increased&in&recent&years.1&This&increase&has&been&associated&with&human&
papillomavirus& infection,& particularly& the& highhrisk& HPVh16& subtype,& in& cancers& of& the&
oropharynx.2&Oral&epithelial&dysplasia&(OD)&is&a&known&premalignant&condition&associated&
with&oral&squamous&cell&carcinoma&(OSCC).&Clinically,&OD&lesions&appear&as&white&or&red&
patches& (leukoplakia&and&erythroplakia& respectively)&occurring&anywhere&on& the&mucosal&
surfaces&of&the&mouth.&
&Although&histological&assessment&is&the&gold&standard&for&diagnosis&and&the&grade&
of&OD& is&a& key& risk& factor& of&malignant& transformation,& its& assessment& is& subjective&with&
substantial& interhobserver& variability.3,& 4& Moreover,& the& majority& of& OD& lesions& do& not&
progress&to&cancer:&reported&progression&rates&ranged&between&6%&and&36%.5,&6&
Although& significant& efforts& have& been& made& to& improve& the& predictive& value& of&
histological& grading,& e.g.& by& combining&DNA& ploidy& analysis& with&OD& grading,7& accurate&
positive&predictive&markers&of&progression&do&not&exist.8,&9&The&mainstay&treatment&for&OD&
remains& regular& surveillance& and& surgical& resection,10& and& patients& with& recurrence& (10h
20%&of& those&with&OD)&may& require&multiple&operations& in&an&anatomically&confined&and&
complex&region&with&significant&impact&on&quality&of&life.&&Hence,&improved&understanding&of&
the& molecular& mechanisms& underlying& the& progression& from& OD& to& OSCC& could& help&
stratify&risks&of&patients&with&OD&and&streamline&their&followhup,&with&the&potential&to&identify&
malignant& transformation& early,& while& minimising& morbidity& from& active& surveillance& and&
repeat&resections.11&
Key& proteins& in& cell& cycle& and& proliferation& control& have& been& evaluated& as&
candidate&biomarkers&to&predict&progression&in&OD,&with&limited&success.12&Senescence&is&
an&irreversible&form&of&growth&arrest&and,&once&it&is&established,&cells&are&unable&to&express&
genes& required& for&proliferation&even&when&exposed& to&mitogenic&growth& factors.&Hence,&
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senescence& is& a& potent&mechanism&of& tumour& suppression,& associated&with& human& and&
mouse& benign& neoplastic& lesions.11,& 13& Senescent& cells& continue& to& remain&metabolically&
active& with& characteristic& large& flattened&morphology& (at& least& in& vitro),& and& also& display&









senescence& was& altered& in& OD,& compared& to& normal& oral& epithelium.& In& addition,& the&
predictive&potential&of&these&markers&was&explored.&&&
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Anonymised& surplus& formalin& fixed& and& paraffin& embedded& (FFPE)& specimens& of&
OD& and& OSCC& were& retrospectively& identified& and& retrieved& from& the& NHS& Greater&





Agehmatched& healthy& volunteers& were& identified& at& the& head& and& neck& surgical&
outpatient&clinic&of&the&Queen&Elizabeth&University&Hospital&(Glasgow,&the&United&Kingdom)&
by& a& consultant& surgeon& (JDM)& who& provided& routine& care& of& the& volunteers.& Study&
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Immunohistochemistry%%
Histology& slides& were& stained& for& markers& of& proliferation& (Ki67,& CycD1),& DNA&
damage/checkpoint& markers& (!H2AX),& cellular& senescence& (p53& and& p16),& chromatin&
structure&(trimethylhHistone&H3&(Lys9)&[H3K9me3])&and&negative&control&(IgG)&according&to&




9106,& Thermo& Scientific,& Clone& SP6)& at& 1& in& 200q& γH2AX& (9718,& Cell& Signaling,& Clone&
20E3)& at& 1& in& 50q& p53& (M7001,& Novacastral,& Clone& DO7)& at& 1& in& 1000q& p16& (725h4713,&
Roche,&Clone&E6H4)&was&used&as&received,&H3K9me3&(07h442,&Millipore,&polyclonal)&at&1&
in& 300q&CycD1& (M3635,&Dako,&Clone&SP4)& at& 1& in& 50q&M7023& (negative& control,& Sigmah
Aldrich,& polyclonal)& at& 1& in& 9000.& Apart& from& p16& and& CycD1& staining,& all& staining& was&
performed&after&heathinduced&epitope&retrieval&in&citrate&buffer&at&pH6.&For&p16&and&CycD1&




Stained& slides& were& digitised& (Hamamatsu& NanoZoomer& NDP,& Hamamatsu&
Photonics,& Welwyn& Garden& City,& UK),& reviewed& and& analysed& using& Slidepath& Digital&
Image&Hub&V4.0.7&(Leica&Microsystems,&Milton&Keynes,&UK).&&
Histological&grade&of&OD&and&qualitative&assessments&of& the&histology&slides&were&
performed& by& two& collaborating& pathologists& (KH& and& CEM),& who& were& blinded& to& the&
histological& grade& of& the& original& diagnostic& report& at& the& time& of& their& assessments.& As&
discrete&areas&of&OD&often&develop&within&a&background&of&normal&tissue,&three&separate&
areas&representing&the&highest&severity&of&OD&on&each&slide&were&digitally&annotated&based&
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generated&by&digital& image&analysis.&Mean&values&of& the&histoscores&generated& from& the&






The& HPV& status& of& p16hpositive& specimens& was& evaluated& by& HPV& 16/18&
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Results%
The%relationships%between%grade%of%disease%and%biomarkers%assessed%
& For& the& archival& specimens& (n=86),& only& age& and& histological& grade& at& diagnosis&
were&available.&The&median&age&of&diagnosis&was&64.6&years&old&(interquartile&range:&53.9h
71.5).& Twentyhfour& (27.9%)& of& these& archival& specimens& had& mild& OD,& 17& (19.8%)& had&
moderate& OD,& 32& (37.2%)& had& severe& OD& and& 13& (15.1%)& had& OSCC.& Automated&
histoscores& of& the& assessed& immunohistochemical&markers&were& compared& by& grade& of&
disease,& compared& to& 24& normal& agehmatched& controls& (Table& 1,& Figure& 1& and&
supplementary& Figure& 1).& With& respect& to& p16& expression,& seven& of& the& 32& severe& OD&
specimens& (21.9%)& expressed& a& high& level& of& p16.&Given& the& known& link& between&HPV&
status&and&p16,&their&HPV&status&was&evaluated.&Five&were&HPV&positive&(71.4%,&all&HPVh
16& positive),& one& was& negative& (14.3%)& and& one& had& too& little& remaining& DNA& for&
assessment&(14.3%).&








with& disease& progression,& the& median& time& to& progression& was& 6.0& years& (IQR:& 4h6.9).&
There&was&no&difference&in&the&rate&of&progression&by&grade&of&dysplasia&(supplementary&
figure&2,&p=0.73).&
& The& relationships& between& assessed& biomarkers& and& disease& progression& in&
patients&with&OD&were&evaluated&(Table&2).&Two&of&the&7&patients&with&a&high&level&of&p16&
! ! ! 11!
(28.6%)&progressed& to& develop&OSCC,&of&whom&only& one&had& confirmed&HPV& infection.&
Most& interestingly,& increased& !H2AX&was& associated&with& disease& progression& (Table& 2,&
p=0.03).&Using& the&median& histoscore& for& !H2AX& (median& histoscore& =& 17)& as& a& cuthoff,&






γH2AX& and& p53,& and& subsequently& plateaued& or& reversed& in& patients& with& malignancy,&
similar& to& changes& observed& in& patients& with& Barrett’s& oesophagus.16&Moreover,& !H2AX,&
which&predictive&value&has&not&been& thoroughly&evaluated6,&was&associated&with&disease&
progression.&
Although& p16& expression& is& an& established& marker& of& senescence,& infection& with&
HPV&upregulates&expression&of&nonhfunctional&p16&due&to&the&loss&of&pRB&function,&which&
is& unlikely& to& be& associated& with& senescence.& Indeed,& in& patients& with& severe& OD,& the&
majority&of&specimens&with&high&p16&expression&had&confirmed&HPV&infection.&Consistent&
with& previous& reports& that& only& a& small& proportion& of& patients& with& OSCC& (<5%)& were&
infected&with&HPV17& and& that& p16&was&a& poor& predictive&marker& of&OD8,&18,& p16&was&not&
associated&with& increasing&histological&grade&of&OD&nor&progression& in& this&cohort.&Other&
novel& senescence& markers& assessed& in& this& study& did& not& show& significant& changes& in&
expression&by&grade&of&OD&or&progression&status.&&
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to&malignancy&was& similar& to& that& in& previously& reported& studies& (26%).5,& 6&However,& the&
number&of&participants&included&in&this&exploratory&study&was&small.&It&had&limited&power&to&





& The& expression& of& proliferation& markers& Ki67,& DNA& damage/checkpoint& markers&
!H2AX&and&p53&was&significantly&higher&with&increasing&grades&of&OD,&which&may&aid&the&
determination& of& histological& grade& of& OD.& The& significance& of& the& observed& patterns& of&
expression&of&Ki67,& !H2AX& in&and&p53& in&OSCC& is&unclear.& Including&normal& controls& in&
future&biomarker&studies&will&help&confirm&the&patterns&observed.&&&&
While& grade& of& dysplasia& did& not& predict& progression& in& this& cohort& of& patients,&
!H2AX& overexpression& was& significantly& associated& with& disease& progression,& with& p53&
showing&a&similar&trend.&It&was&previously&proposed&that&DNA&replication&stress,&consistent&
with& !H2AX& overexpression& observed,& may& promote& genomic& instability& that& may&
encourage&progression&from&OD&to&OSCC.21&Future&studies&could&further&evaluate&whether&





p53& were& increased& in& higher& grade& of& OD,& only& !H2AX& was& associated& with& disease&
progression,& which& may& indicate& the& potential& of& DNA& replicative& stress& in& the&
transformation&from&OD&to&OSCC.&Larger&studies&could&evaluate&whether&!H2AX&could&be&
used&as&a&predictive&marker&of&OD.&
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Table&1:&Automated&histoscores&by&grade&of&disease,&compared&to&normal&healthy&control&(n=110).&1!
&2!
& Normal' Mild'OC' Moderate'OC' Severe'OC' OSCC' p2value'
Ki67' 58.3&(47.2E69.5)& 56.5&(45.1E74.1)& 78.0&(47.0E105.2)& 94.3&(82.3E121.0)& 71.3&(40.0E110.0)& <0.0001%
γH2AX' 11.3&(7.7E19.2)& 13.8&(8.5E17.9)& 16.0&(7.7E41.4)& 25.5&(11.3E62.3)& 27.0&(4.0E46.2)& 0.03%
p53' 13.5&(4.4E22.2)& 37.9&(12.7E43.7)& 39.7&(14.4E95.3)& 17.7&(3.0E111.3)& 19.0&(2.3E75.5)& 0.04%
p16' 0&(0E1.0)& 0.3&(0E2.8)& 0&(0E1.0)& 0&(0E5.0)& 0&(0E0.7)& 0.59&
H3K9me3' 74.0&(58.3E95.1)& 76.5&(56.6E111.3)& 77.7&(17.5E105.9)& 66.2&(36.1E108.2)& 63.3&(39.3E94.0)& 0.68&
CycD1' 31.5&(16.9E67.5)& 23.5&(8.3E51.3)& 29.0&(9.5E&71.8)& 42.2&(8.9E76.8)& 56.3&(30.4E82.9)& 0.19&
M7023'










Ki67' 81.0&(47.8E114.7)& 83.0&(60.3E101.7)& 0.65&
γH2AX' 15.3&(8.6E26.9)& 25.5&(14.5E56.0)& 0.04%
p53' 28.9&(7.8E56.3)& 69.2&(9.9E95.9)& 0.15&
p16' 0.2&(0E3.0)& 0&(0E0.7)& 0.19&
H3K9me3' 70&(36.5E105.1)& 80&(51.2E112.0)& 0.55&
CycD1' 28.5&(7.9E58.7)& 49.0&(12.7E75.3)& 0.11&
M7023'
(Negative'control)' 0.3&(0E1.3)& 0&(0E0.9)& 0.54&
Data&presented&as&median&(IQR)&3!
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Supplementary'figure'2:'Progression'status'by'grade'of'OD.'1!
'2!
'3!
'4!
